Skip to main content
Top
Published in: International Journal of Hematology 4/2017

01-10-2017 | Images in Hematology

Myelomonocytic leukemia with intracytoplasmic crystalline inclusions, double minute chromosomes and MYC amplification

Authors: Julia T. Geyer, Susan Mathew

Published in: International Journal of Hematology | Issue 4/2017

Login to get access

Excerpt

The patient is an 83-year-old man with a history of coronary artery disease status post two bypass surgeries. Shortly after admission, he was found to have severe anemia requiring blood transfusions. The patient also noted easy bruising. A CBC revealed a hemoglobin of 8.6 g/dL, a platelet count of 12 × 103/μL and a white blood cell count of 7.0 × 103/μL with an absolute monocytosis (1.5 × 103/μL). Bone marrow biopsy showed a myelomonocytic neoplasm with increased blasts. Precise enumeration of blasts, immature myeloid precursors and immature monocytes was difficult due to the presence of marked dysgranulopoiesis (Fig. 1, top panel). Immature myeloid cells contained peculiar rectangular-shaped salmon-pink inclusions (Fig. 1, top panel). Conventional cytogenetic analysis demonstrated a simple karyotype with 3–24 copies of double minutes composed of amplified MYC verified by interphase FISH (Fig. 1, bottom panel). A next-generation sequencing panel revealed mutations in DNMT3A, NRAS, TET2, U2AF1, and WT1. Double minutes are small chromatin particles that lack a centromere and represent a form of extrachromosomal gene amplification. They are occasionally seen in hematologic malignancies and are frequently associated with MYC amplification. Presence of double minutes has been reported predominantly in AML, followed by MDS, and, rarely, CMML. In this patient, the sudden clinical presentation, presence of double minutes, and the molecular genetic profile favor AML with monocytic differentiation over CMML. Similar intracytoplasmic crystalline inclusions have been reported in two patients with AML-M4, one patient with CMML [1], and two acute promyelocytic leukemia patients with variant RARA translocations: t(X;17)(p11;q12); BCOR-RARA [2] and t(11;17)(q23;q21); ZBTB16-RARA [3]. Of note, immunoglobulin-containing intracytoplasmic crystals in lymphocytes of patients with chronic lymphocytic leukemia may have a virtually identical morphologic appearance [4]. The most recently reported case of CMML also showed evidence of double minutes with MYC amplification. The treatment outcome was poor, including in the patient reported here, who did not respond to DNA methyltransferase inhibitor and was put on comfort care 6 months after diagnosis. Thus, presence of intracytoplasmic crystalline inclusions in myeloid cells may be a feature of aggressive myelomonocytic neoplasms with double minutes composed of amplified MYC.
Literature
1.
go back to reference Miyazaki K, Suzuki K. Unusual intracytoplasmic crystalline inclusions in chronic myelomonocytic leukemia with double minute chromosomes and MYC amplification: a rare case. Acta Haematol. 2014;132:68–72.CrossRefPubMed Miyazaki K, Suzuki K. Unusual intracytoplasmic crystalline inclusions in chronic myelomonocytic leukemia with double minute chromosomes and MYC amplification: a rare case. Acta Haematol. 2014;132:68–72.CrossRefPubMed
2.
go back to reference Yamamoto Y, Tsuzuki S, Tsuzuki M, et al. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood. 2010;116:4274–83.CrossRefPubMed Yamamoto Y, Tsuzuki S, Tsuzuki M, et al. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood. 2010;116:4274–83.CrossRefPubMed
3.
go back to reference Dowse RT, Ireland RM. Variant ZBTB16-RARA translocation: morphological changes predict cytogenetic variants of APL. Blood. 2017;129:2038.CrossRefPubMed Dowse RT, Ireland RM. Variant ZBTB16-RARA translocation: morphological changes predict cytogenetic variants of APL. Blood. 2017;129:2038.CrossRefPubMed
4.
go back to reference Hurez D, Flandrin G, Preud’homme JL, et al. Unreleased intracellular monoclonal macroglobulin in chronic lymphocytic leukaemia. Clin Exp Immunol. 1972;10:223–34.PubMedPubMedCentral Hurez D, Flandrin G, Preud’homme JL, et al. Unreleased intracellular monoclonal macroglobulin in chronic lymphocytic leukaemia. Clin Exp Immunol. 1972;10:223–34.PubMedPubMedCentral
Metadata
Title
Myelomonocytic leukemia with intracytoplasmic crystalline inclusions, double minute chromosomes and MYC amplification
Authors
Julia T. Geyer
Susan Mathew
Publication date
01-10-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2299-9

Other articles of this Issue 4/2017

International Journal of Hematology 4/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine